[The prevention of diarrhea while under capecitabine therapy].
Grouls
V
V
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced / Q000517:prevention & control*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D043322:Lactase / Q000008:administration & dosage / Q000172:deficiency; D007785:Lactose / Q000009:adverse effects
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D043322:Lactase; D007785:Lactose; D005472:Fluorouracil